Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Superficial Bladder Cancer
NCT00004154Phase 3Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 1998
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenretinide in bladder cancer, sponsored by University of Texas MD Anderson Cancer Center. Started Jul 1998; status: completed.
02
Drugs
fenretinide
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00004154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004154.